ALEMBIC LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 104.2 INR | +1.31% |
|
+14.32% | +15.01% |
| May. 30 | Alembic Pharmaceuticals Gets US FDA Final Nod for Sacubitril and Valsartan Tablets | MT |
| May. 13 | Alembic Limited Recommends Dividend for the Year Ended 31 March, 2024 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bullish |
| Resistance | 106.51 | 106.51 | 103.21 |
| Spread/Res. | -1.92% | -1.92% | +1.21% |
| Spread/Supp. | +21.39% | +30.71% | +18.31% |
| Support | 86.05 | 79.92 | 88.29 |
- Stock Market
- Equities
- ALEMBICLTD Stock
- Charts Alembic Limited
